Nuclear reprogramming with a non-integrating human RNA virus

por Driscoll, Christopher B, Tonne, Jason M, El Khatib, Moustafa, Cattaneo, Roberto, Ikeda, Yasuhiro, Devaux, Patricia
Publicado 2015

Seizure as Presenting Symptom of Multisystem Inflammatory Syndrome in Children

por D'Ambrosio, Eleonora S., Gauguet, Stefanie, Miller, Christine, McMahon, Erin, Driscoll, Christopher, Mohanty, Mugdha, Guggina, Thomas
Publicado 2023

miRNA-mediated control of exogenous OCT4 during mesenchymal-epithelial transition increases measles vector reprogramming efficiency

por Rallabandi, Ramya, Sharp, Brenna, Cruz, Conrad, Wang, Qi, Locsin, Alexis, Driscoll, Christopher B., Lee, Ella, Nelson, Tim, Devaux, Patricia
Publicado 2021

Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity

por Schuelke, Matthew R., Wongthida, Phonphimon, Thompson, Jill, Kottke, Timothy, Driscoll, Christopher B., Huff, Amanda L., Shim, Kevin G., Coffey, Matt, Pulido, Jose, Evgin, Laura, Vile, Richard G.
Publicado 2019

Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors

por Wongthida, Phonphimon, Schuelke, Matthew R, Driscoll, Christopher B, Kottke, Timothy, Thompson, Jill M, Tonne, Jason, Stone, Cathy, Huff, Amanda L, Wetmore, Cynthia, Davies, James A, Parker, Alan L, Evgin, Laura, Vile, Richard G
Publicado 2020

APOBEC3 Mediates Resistance to Oncolytic Viral Therapy

por Huff, Amanda L., Wongthida, Phonphimon, Kottke, Timothy, Thompson, Jill M., Driscoll, Christopher B., Schuelke, Matthew, Shim, Kevin G., Harris, Reuben S., Molan, Amy, Pulido, Jose S., Selby, Peter J., Harrington, Kevin J., Melcher, Alan, Evgin, Laura, Vile, Richard G.
Publicado 2018

APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy

por Driscoll, Christopher B., Schuelke, Matthew R., Kottke, Timothy, Thompson, Jill M., Wongthida, Phonphimon, Tonne, Jason M., Huff, Amanda L., Miller, Amber, Shim, Kevin G., Molan, Amy, Wetmore, Cynthia, Selby, Peter, Samson, Adel, Harrington, Kevin, Pandha, Hardev, Melcher, Alan, Pulido, Jose S., Harris, Reuben, Evgin, Laura, Vile, Richard G.
Publicado 2020

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

por Evgin, Laura, Huff, Amanda L., Wongthida, Phonphimon, Thompson, Jill, Kottke, Tim, Tonne, Jason, Schuelke, Matthew, Ayasoufi, Katayoun, Driscoll, Christopher B., Shim, Kevin G., Reynolds, Pierce, Monie, Dileep D., Johnson, Aaron J., Coffey, Matt, Young, Sarah L., Archer, Gary, Sampson, John, Pulido, Jose, Perez, Luis Sanchez, Vile, Richard
Publicado 2020

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy

por Kottke, Timothy, Tonne, Jason, Evgin, Laura, Driscoll, Christopher B., van Vloten, Jacob, Jennings, Victoria A., Huff, Amanda L., Zell, Brady, Thompson, Jill M., Wongthida, Phonphimon, Pulido, Jose, Schuelke, Matthew R., Samson, Adel, Selby, Peter, Ilett, Elizabeth, McNiven, Mark, Roberts, Lewis R., Borad, Mitesh J., Pandha, Hardev, Harrington, Kevin, Melcher, Alan, Vile, Richard G.
Publicado 2021